Aberdeen Group plc Acquires 30,723 Shares of Amdocs Limited $DOX

Aberdeen Group plc boosted its stake in Amdocs Limited (NASDAQ:DOX) by 13.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 263,287 shares of the technology company’s stock after purchasing an additional 30,723 shares during the period. Aberdeen Group plc’s holdings in Amdocs were worth $21,197,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Scotia Capital Inc. raised its holdings in Amdocs by 3.5% during the 3rd quarter. Scotia Capital Inc. now owns 4,289 shares of the technology company’s stock valued at $352,000 after acquiring an additional 145 shares during the period. CENTRAL TRUST Co increased its position in shares of Amdocs by 6.1% during the 3rd quarter. CENTRAL TRUST Co now owns 2,741 shares of the technology company’s stock valued at $225,000 after purchasing an additional 158 shares during the last quarter. WealthCollab LLC boosted its stake in shares of Amdocs by 94.5% in the 3rd quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock valued at $29,000 after purchasing an additional 173 shares in the last quarter. Rossby Financial LCC boosted its position in Amdocs by 39.3% during the third quarter. Rossby Financial LCC now owns 620 shares of the technology company’s stock valued at $50,000 after buying an additional 175 shares during the period. Finally, Blair William & Co. IL grew its holdings in shares of Amdocs by 5.5% in the third quarter. Blair William & Co. IL now owns 3,393 shares of the technology company’s stock worth $278,000 after purchasing an additional 177 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors.

Amdocs Stock Performance

Shares of DOX stock opened at $66.43 on Monday. The stock has a market capitalization of $7.17 billion, a price-to-earnings ratio of 12.85, a price-to-earnings-growth ratio of 1.17 and a beta of 0.46. The stock’s 50-day moving average price is $69.72 and its 200-day moving average price is $77.05. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23. Amdocs Limited has a 12-month low of $63.33 and a 12-month high of $95.41.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The business had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.15 billion. During the same period last year, the company posted $1.66 EPS. The business’s revenue was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Equities research analysts predict that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.569 per share. This represents a $2.28 dividend on an annualized basis and a yield of 3.4%. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date is Tuesday, March 31st. Amdocs’s dividend payout ratio (DPR) is presently 44.10%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Stifel Nicolaus dropped their target price on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Wall Street Zen cut Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Barclays cut their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, February 4th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $92.33.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.